Skip to main content

Table 4 Putative metabolites observed using accurate mass after two-hour incubation with pooled human hepatocytes with retention times (rt), observed m/z and transitions

From: CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine

Putative Metabolite (HH)

Formula

m/z

ppm

rt (min)

Peak Area

% Area

Loss of C5H11N and CH2

C9H8N2O

161.0704

−3.2

1.36

9.02E + 03

0.1

Loss of CH2+ Gluc. Conj.

C20H27N3O7

422.1910

−2.9

1.94

3.87E + 03

0.0

Oxidation*

C15H21N3O2

276.1706

−0.2

2.18

1.39E + 04

0.2

Loss of CH2*

C14H19N3O2

246.1603

0.8

2.52

4.06E + 04

0.5

Ketone Formation

C15H19N3O2

274.1552

0.9

2.64

5.30E + 03

0.1

Oxidation*

C15H21N3O2

276.1705

−0.5

3.68

8.42E + 03

0.1

Oxidation*

C15H21N3O2

276.1705

−0.5

4.22

1.45E + 04

0.2

Loss of NH + Oxidation and Gluc. Conj.

C21H28N2O8

437.1916

−0.5

6.21

5.21E + 03

0.1

Carbamoyl Glucoronide

C22H29N3O9

480.1971

−1.1

6.40

3.72E + 04

0.4

Oxidative Deamination to Acid

C15H18N2O3

275.1402

4.3

7.14

6.65E + 05

7.4

Oxidative Deamination to Alcohol***

C15H20N2O2

261.1600

0.8

7.14

3.01E + 04

0.3

  1. Metabolites observed after two-hour incubation with pooled human hepatocytes with retention times (rt), observed m/z, ppm deviance from expected mass defect, peak area, and % total chromatographic area. Bolded metabolites can be accounted for as arising from either 2D6 * or MAO-A** metabolism, or were observed in both ***